Activity of oral agents against pediatric isolates of Streptococcus pneumoniae

被引：3
|
作者：
Black, J
Moland, ES
Chartrand, SA
Thomson, KS
机构：
[1] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Ctr Res Anti Infect & Biotechnol, Omaha, NE 68178 USA
[2] Creighton Univ, Sch Med, Dept Pediat Infect Dis, Omaha, NE 68178 USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2001年 / 39卷 / 03期
关键词：
D O I：
10.1016/S0732-8893(01)00209-7
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
An in vitro study of the activity of 10 oral agents against 153 pediatric isolates of Streptococcus pneumoniae identified moxifloxacin and levofloxacin as the most active agents regardless of penicillin or macrolide susceptibility. Moxifloxacin inhibited all strains at 0.25 mug/ml and was 8- to 16-fold more potent than levofloxacin. (C) 2001 Elsevier Science inc. All rights reserved.
引用
收藏
页码：195 / 197
页数：3
相关论文
共 50 条
  • [1] In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin
    Fenoll, A.
    Gimenez, M. J.
    Robledo, O.
    Aguilar, L.
    Tarrago, D.
    Granizo, J. J.
    Gimeno, M.
    Coronel, P.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (02) : 175 - 179
  • [2] Activity of faropenem against resistant isolates of Streptococcus pneumoniae
    Black, JA
    Moland, ES
    Chartrand, SA
    Thomson, KS
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 41 (1-2) : 89 - 92
  • [3] Activity of grepafloxacin against respiratory isolates of Streptococcus pneumoniae
    Johnson, AP
    Warner, M
    Parsons, T
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (08) : 622 - 623
  • [4] Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae
    Esposito, S
    Noviello, S
    Ianniello, F
    CHEMOTHERAPY, 2001, 47 (02) : 90 - 96
  • [5] In vitro activity of gatifloxacin against Streptococcus pneumoniae isolates in Germany
    Reinert, RR
    Al-Lahham, A
    Lemmen, S
    Lütticken, R
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (05) : 854 - 856
  • [6] Activity of trovafloxacin against blood isolates of Streptococcus pneumoniae in Sweden
    OlssonLiljequist, B
    Hoffman, BM
    Hedlund, J
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (08) : 671 - 675
  • [7] In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany
    Lemmen, S
    Al-Lahham, A
    Lütticken, R
    Reinert, RR
    CHEMOTHERAPY, 2001, 47 (02) : 104 - 109
  • [8] Activity of telithromycin and seven other agents against 1034 pediatric Streptococcus pneumoniae isolates from ten central and eastern European centers
    Bozdogan, B
    Appelbaum, PC
    Kelly, LM
    Hoellman, DB
    Tambic-Andrasevic, A
    Drukalska, L
    Hryniewicz, W
    Hupkova, H
    Jacobs, MR
    Kolman, J
    Konkoly-Thege, M
    Miciuleviciene, J
    Pana, M
    Setchanova, L
    Trupl, J
    Urbaskova, P
    CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (07) : 653 - 661
  • [9] In vitro activity of ceftobiprole and seven other antimicrobial agents against invasive Streptococcus pneumoniae isolates in Spain
    E. Ríos Dueñas
    I. Rodríguez-Avial
    J. J. Picazo
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30 : 1621 - 1625
  • [10] In vitro activity of ceftobiprole and seven other antimicrobial agents against invasive Streptococcus pneumoniae isolates in Spain
    Rios Duenas, E.
    Rodriguez-Avial, I.
    Picazo, J. J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (12) : 1621 - 1625
12345